Vomiting News and Research

RSS
Vomiting is the process the body uses to eject some or all of the contents of the stomach through the mouth.
BARACLUDE sNDA receives FDA approval for treatment of CHB patients with decompensated liver disease

BARACLUDE sNDA receives FDA approval for treatment of CHB patients with decompensated liver disease

14 global studies on osteoporosis medications FORTEO and EVISTA to be presented at ASBMR 2010

14 global studies on osteoporosis medications FORTEO and EVISTA to be presented at ASBMR 2010

Botox receives FDA approval for treatment of chronic migraine

Botox receives FDA approval for treatment of chronic migraine

GI Dynamics' EndoBarrier therapy to treat type 2 diabetes and obesity granted European CE mark approval

GI Dynamics' EndoBarrier therapy to treat type 2 diabetes and obesity granted European CE mark approval

Scientists to monitor effectiveness of Streptococcus vaccine

Scientists to monitor effectiveness of Streptococcus vaccine

Journal of Clinical Oncology publishes IPI-504 Phase 2 study results

Journal of Clinical Oncology publishes IPI-504 Phase 2 study results

Administering ondansetron drug to children is economically advantageous

Administering ondansetron drug to children is economically advantageous

FDA approves Gamunex-C for primary immunodeficiency treatment

FDA approves Gamunex-C for primary immunodeficiency treatment

Archimedes publishes results from FPNS Phase III clinical study for breakthrough cancer pain

Archimedes publishes results from FPNS Phase III clinical study for breakthrough cancer pain

Alkermes' VIVITROL medication for treatment of opioid dependence

Alkermes' VIVITROL medication for treatment of opioid dependence

FDA approves Vivitrol for treatment of opioid-dependent patients

FDA approves Vivitrol for treatment of opioid-dependent patients

Combination therapy for ovarian cancer leads to greater toxicity

Combination therapy for ovarian cancer leads to greater toxicity

Early cancer drug trials flawed by inconsistencies in prohibited drug lists, study finds

Early cancer drug trials flawed by inconsistencies in prohibited drug lists, study finds

Sales of Merck's telcagepant and CoLucid's lasmiditan in world's major markets to reach $1.3 billion in 2019

Sales of Merck's telcagepant and CoLucid's lasmiditan in world's major markets to reach $1.3 billion in 2019

Eli Lilly presents ALIMTA Phase III trial results at ESMO Annual Meeting

Eli Lilly presents ALIMTA Phase III trial results at ESMO Annual Meeting

Afinitor-Sandostatin LAR Depot combination extends median PFS in patients with advanced carcinoid tumors

Afinitor-Sandostatin LAR Depot combination extends median PFS in patients with advanced carcinoid tumors

FDA warns of harmful stimulant in Slimming Beauty capsules

FDA warns of harmful stimulant in Slimming Beauty capsules

Abbott to withdraw Meridia medicine from the U.S. market

Abbott to withdraw Meridia medicine from the U.S. market

Pfizer announces tasocitinib Phase 2 data for plaque psoriasis

Pfizer announces tasocitinib Phase 2 data for plaque psoriasis

Hizentra therapy effective for primary immunodeficiency patients

Hizentra therapy effective for primary immunodeficiency patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.